Global eClinical solutions market to reach USD 31.90 billion by 2032, driven by digital technology adoption
From GlobeNewswire: 2025-03-07 09:10:00
The global eClinical Solutions Market was valued at USD 9.82 billion in 2023 and is projected to reach USD 31.90 billion by 2032, with a CAGR of 14.02% during 2024-2032. The rise in digital technology adoption in clinical research is a key driver for this growth, as highlighted by SNS Insider.
Electronic systems are revolutionizing data collection, management, and analysis for clinical trials. Tools like EDC, CTMS, and eCOA are essential for improving trial efficiency and data quality. The demand for advanced digital tools has increased due to rising clinical trial complexity and regulatory requirements.
Major players in the eClinical Solutions Market include Fountayn, Oracle, Calyx, Medidata, CRF Health, and more. These companies offer a range of eClinical platforms to meet the diverse needs of the industry.
In 2023, the CTMS segment led the market in revenue share, while the eCOA segment is expected to grow the fastest. Cloud and web-based delivery modes dominated the market, with on-premise solutions expected to grow in the future.
The market is segmented by product, delivery mode, development phase, and end-use. CROs were the dominant players in 2023, benefiting from the outsourcing trend in clinical trials. North America held the largest revenue share, while the Asia Pacific region is expected to show the fastest growth.
Recent developments in the eClinical Solutions Market include eClinical Solutions LLC adding 20 new customers and collaborating with top pharmaceutical companies, expanding its market footprint. The market continues to evolve with advancements in digital technology and data management systems. In October 2024, Medidata released a next-generation eCOA platform to enhance patient engagement and data quality, integrating easily with existing clinical trial management systems for real-time data capture and analysis. Additionally, eClinical Solutions partnered with Snowflake to streamline clinical data management and strengthen AI-driven analytics in December 2024.
Statistics show that 85% of pharmaceutical companies have adopted eClinical solutions, reducing clinical trial costs by 30% and improving data accuracy by 25%. These solutions can also shorten clinical trials by at least 20%, allowing new treatments to reach the market faster. A report on the eClinical Solutions Market Analysis & Outlook from 2024-2032 is available for purchase, providing detailed insights and trends in the industry.
Read more at GlobeNewswire: Global eClinical Solutions Market Size to Hit USD 31.90